Chiral probes may provide crucial information on many aspects of drug action. Enantioselective and eudismic analyses are two methods that use enantiomeric pairs to study drug-receptor interactions. They are particularly useful in characterizing binding sites and receptor subtypes. The principles of the approaches and their uses are briefly examined. A few examples illustrating the possible results are discussed.
AriensEJ. Stereochemistry: A source of problems in medicinal chemistry. Part I. Med Res Rev. 1986;6: 451–466.
2.
AriensEJ. Stereochemistry in the analysis of drug-action. Part II. Med Res Rev. 1987;7: 367–387.
3.
JamaliFMehvarRPasuttoFM. Enantioselective aspects of drug-action and disposition: Therapeutic Pitfalls. J Pharm Sci. 1989;78: 695–715.
4.
SmithDF. The Stereoselectivity of drug-action. Pharmacol Toxicol. 1989;63: 321–331.
5.
TeodoriEGualtieriFAngeliPBrasiliLGiannellaMPiginiM. Resolution, absolute configuration, and cholinergic enantioselectivity of (+)-and (–)-cis-2-methyl-5-[(dimethylamino)methyl]-1, 3-oxathiolane methiodide. J Med Chem. 1986;29: 1610–1615.
6.
TeodoriEGualtieriFAngeliPBrasiliLGiannellaM. Resolution, absolute configuration, and cholinergic enantioselectivity of (+)- and (—)-c-2- methyl-r-5-[(dimethylamino)methyl]-1, 3-oxathiolane t-3-oxide methiodide and related sulfones. J Med Chem. 1987;30: 1934–1938.
7.
LevyRHBoddyAV. Stereoselectivity in Pharmacokinetics: a general theory. Pharm Res. 1991;8: 551–556.
AriensEJ. Stereoselectivity of bioactive agents: general aspects. In: AriensEJSoudijnWTimmermansPBMWM. eds. Stereochemistry and biological activity of drugs. Oxford, England: Blackwell Scientific Publications; 1983;11–32.
10.
PommerenkeEWMatternJTraugottU. Volm M. Durchbrechung der multidrug-resistenz mit (R)-Verapamil in vitro und in vivo. Arzneim Forsch/Drug Res. 1991;41: 855–858.
11.
RomanelliMNTeodoriEGualtieriFAngeliPBrasiliL. Enantioselectivity of muscarinic antagonists. 2, 2-Dicyclohexyl-5-[(dimethylamino)-methyl]-1, 3-oxathiolane methiodides and related 3-oxides. J Med Chem. 1988;31: 1698–1702.
12.
RomanelliMNGualtieriFValleGBrasiliLAngeliP. Enantioselectivity of muscarinic antagonists. Isomeric 2-cyclohexyl-2-phenyl-5-[(dimethylamino)methyl]-1, 3-oxathiolane methiodides. J Med Chem. 1988;31: 1703–1708.
13.
GualtieriFRomanelliMNTeodoriE. On the site of interaction of some muscarinic agonists and competitive antagonists. II Farmaco. 1989;44: 897–909.
14.
PatilPNPatelDGKrellRD. Steric aspects of adrenergic drugs. XV. Use of isomeric activity ratio as a criterion to differentiate adrenergic receptors. J Pharmacol Exper Ther. 1971;176: 622–633.
15.
AngeliPBrasiliLGiannellaMGualtieriFPicchioMTTeodoriE. Chiral muscarinic agonists possessing a 1, 3-oxathiolane nucleus: enantio-and tissue-selectivity on isolated preparations of guinea-pig ileum and atria and of rat urinary bladder. Naunyn-Schmiedeberg's Arch Pharmacol. 1988;337: 241–245.
16.
MorrisTHKaumannAJ. Different steric characteristics of β1- and β2-adrenoceptors. Naunyn-Schmiedeberg Arch Pharmacol. 1984;327: 176–179.
17.
ElzeMFigalaV. Affinity and selectivity of biperiden enantiomers for muscarinic receptor subtypes. Eur J Pharmacol. 1988;158: 11–19.
18.
GualtieriFRomanelliMNScapecchiSTeodoriEBartoliniAFantettiLGhelardiniCGiottiA. Muscarinic presynaptic autoreceptors and muscarinic postsynaptic receptors have opposite stereochemical requirements. Med Chem Res. 1991;1: 52–58.
19.
LehmannFPARodrigues de MirandaJFAriensEJ. Stereoselectivity and affinity in molecular pharmacology. Molec Pharmacol. 1976;101–142.
20.
LehmannFPA. Stereoisomerism and drug action. TIPS. 1986;7: 281–285.
21.
PfeifferCC. Optical isomerism and pharmacological action, a generalization. Science. 1956;124: 29–31.
22.
TeodoriERomanelliMNGualtieriF. Pfeiffer's rule and eudismic analysis: stressing the homogeneity of data. In: SilipoC.VittoriaA. eds. QSAR: Rational Approaches to the Design of Bioactive Compounds. Amsterdam: Elsevier Science Publishing BV; 1991:451–456.
23.
El TayarNTestaBVan de WaterbeembHCarruptPAKaumannAJ. Influence of lipophilicity and chirality on the selectivity of ligands for β1- and β2-adrenoceptors. J Pharm Pharmacol. 1988;40: 609–612.
24.
GualtieriFRomanelliMNTeodoriE. Eudismic analysis of a series of muscarinic ligands carrying a 1, 3-oxathiolane nucleus. Chirality. 1990;2: 79–84.
25.
WaelbroeckMTastenoyMCamusJFeifelRMutschlerEStrohmannCTackeRLambrechtGChristopheJ. Stereoselectivity of the interaction of muscarinic antagonists with their receptors. TIPS. Suppl, “Subtypes of muscarinic receptors IV.”1989;65–69.
